PROK (ProKidney Corp.) Total Nilai Perusahaan

ProKidney Pharma - logo grafis emiten PROK

ProKidney Corp. (PROK) relies on a virtual business model, outsourcing drug manufacturing and clinical trials to third-party contractors. The company is developing an innovative cell therapy for kidney regeneration to eliminate the need for dialysis. This Enterprise Value chart on GURU.Markets stands at 1386.35, with the upcoming results of the REACT Phase 3 trials serving as the primary growth driver.

PROK (prokidney.com) riwayat Nilai Total Perusahaan saka 23.11.2025 nganti 28.10.2026
Produk asli ProKidney Corp.

For the high-risk biotech startup ProKidney Corp. (PROK), enterprise value serves as the key metric for investment attractiveness. This metric aggregates market capitalization and debt obligations, minus existing cash and cash equivalents. By analyzing the calculated enterprise value, an investor can determine the actual cost of a full asset buyout. The trend in calculated enterprise value reflects the financing efficiency of R&D and cellular development. This indicator allows for an assessment of the real scale of capital raised to combat diabetes.